Now Is The Time To Bet on CME Group Inc. (CME)’s Stock

    Sammann Derek, Sr MD Gl Hd Commodity & Option, subtracted 6,400 shares of CME Group Inc. (CME) from its portfolio at the rate of $198.83 per share valuing $1,272,512 on Jun 12. The insider left behind 4,757 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of CME Group Inc. (CME) was $196.74. Currently, the 1st Resistance Point for this stock is $198.91, with a 2nd Resistance Point sitting at $201.08. Meanwhile, this company’s stock has a 1st Support Level at $194.53 and a 2nd Support Level at $192.33. CME Group Inc. (CME) stock has lost -$4.15, or -2.07%, in the past five days. In the last full month, these shares have gained $14.44, or 7.92%. In the past three months, this stock’s price has risen by $27.05, or 15.94%. This year-to-date, CME Group Inc. (CME) shares have gained $8.62, or 4.58%.

    Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For CME Group Inc. (CME) stock, 0% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 50% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 100% of long-term indicators suggest that this stock is a “ Buy .”

    With 357,016 K shares outstanding, this company currently has a market capitalization of $71,003,344K. CME Group Inc. (CME) generates $4,309 M in annual sales, amounting to annual net income of $1,962 M. This stock has generated a 1-Year Total Return of 15.40%, a 3-Year Total Return of 109.10%, and a 5-year Total Return of 174.20%. This stock’s 5-Year Dividend Growth is 3.41%, with its most recent dividend valued at $0.750 per share on 06/07/19. Its Annual Dividend Yield is 1.51%, and its Annual Dividend Rate is 3.00.

    In the most recently-reported fiscal quarter, which ended in Mar-19, CME Group Inc. (CME) reported earnings of $1.62 per share. Wall Street analysts, on average, were expecting the company to report earnings of $1.60 per share, representing a 0.02 difference and 1.40% surprise. In the previous quarter ending in Dec-18, the reported earnings of $1.77 represented a 0.04 difference from the consensus estimate calling for $1.73 per share, which was a 2.08% surprise.

    For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $1.61 per share. This estimate came from a total of 5 Wall Street Analysts. Of those market experts, the high estimate was $1.67 and the low estimate was $1.57. In the year-ago quarter, CME Group Inc. (CME) generated per-share earnings of $1.74. If the analysts are correct about the current quarter’s earnings, the growth will be -7.47% .

    Turning our focus now to insider trading activity, there have been 28 purchases (137,628 shares in total) and 47 sale (95,394 shares in total) in the last 3 months. In the last 6 months, there have been 33 insider buys amounting to 163,928 shares and 56 insider sales amounting to 139,343 shares. In the past full year, 91 insider purchases were made (involving 3,261,111 shares) and 125 insider sell-offs equivalent to 236,776 shares.

    Looking at this company’s capital structure, its Total Debt to Total Equity is 16.98, its Total Debt to Total Capital is 14.52, and its Total Debt to Total Assets is now 5.68. Looking even further ahead into the future, its Long-Term Debt to Equity is 14.76 and its Long-Term Debt to Total Capital is 12.62.